Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction

Written by Joe Smith on November 1, 2023

Another weapon in the armoury for people living with Heart Failure with preserved Ejection Fraction (HFpEF) and Heart Failure with mildly reduced Ejection Fraction (HFmrEF) – NICE has recommended Empagliflozin (Jardiance) for HFpEF and HFmrEF. A population that is wholly underserved and underwhelmed with very few treatment options. A win of patients. #BeatHF.